Emerging Sitagliptin Benefit for All-Cause Hospitalizations: Evidence from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)-MedSci.cn

Emerging Sitagliptin Benefit for All-Cause Hospitalizations: Evidence from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

Reed, SD; Li, YH; Leal, J; Graham, F; Alfredsson, J; Gray, AM; Buse, JB; Green, JB; Kaufman, KD; Riefflin, A; Suryawanshi, S; Van de Werf, F; Peterson, ED; Holman, RR

DIABETES, 2017; 66 ( ): A360

科室
- - 订阅+
  - 更多科室
工具
服务